Jessica Mendoza

For each of these diagnoses, insurers received a payment of about $3,000 a year. But when Chris looked into patients' follow-up care, many of them weren't getting it.

For each of these diagnoses, insurers received a payment of about $3,000 a year. But when Chris looked into patients' follow-up care, many of them weren't getting it.

Right, because the point of being diagnosed is so that you can get treatment.

Right, because the point of being diagnosed is so that you can get treatment.

Right, because the point of being diagnosed is so that you can get treatment.

Chris says that because of the way this diagnosis is added to a patient's records, some people may not even know about it. Among the UnitedHealth patients, according to Medicare data, hardly anyone given an HIV diagnosis in that period had started antiretroviral treatment in the following years.

Chris says that because of the way this diagnosis is added to a patient's records, some people may not even know about it. Among the UnitedHealth patients, according to Medicare data, hardly anyone given an HIV diagnosis in that period had started antiretroviral treatment in the following years.

Chris says that because of the way this diagnosis is added to a patient's records, some people may not even know about it. Among the UnitedHealth patients, according to Medicare data, hardly anyone given an HIV diagnosis in that period had started antiretroviral treatment in the following years.

The company said it disputes the journal's analysis, adding that its internal data from a year later, 2022, showed a treatment rate of more than triple what the journal found. Last year, Medicare Advantage insurance companies were paid more than $460 billion. Who ends up paying for that? Where is that money coming from?

The company said it disputes the journal's analysis, adding that its internal data from a year later, 2022, showed a treatment rate of more than triple what the journal found. Last year, Medicare Advantage insurance companies were paid more than $460 billion. Who ends up paying for that? Where is that money coming from?

The company said it disputes the journal's analysis, adding that its internal data from a year later, 2022, showed a treatment rate of more than triple what the journal found. Last year, Medicare Advantage insurance companies were paid more than $460 billion. Who ends up paying for that? Where is that money coming from?

And some of this money was going toward diseases that no doctor ever treated, right? Does that mean the system isn't really working?

And some of this money was going toward diseases that no doctor ever treated, right? Does that mean the system isn't really working?

And some of this money was going toward diseases that no doctor ever treated, right? Does that mean the system isn't really working?

So it sounds like there are some holes in the system.

So it sounds like there are some holes in the system.

So it sounds like there are some holes in the system.

Billing for costly or unnecessary diagnoses, that's one strategy. Another strategy is withholding care from patients who actually need it. The Journal reported on this, too.

Billing for costly or unnecessary diagnoses, that's one strategy. Another strategy is withholding care from patients who actually need it. The Journal reported on this, too.

Billing for costly or unnecessary diagnoses, that's one strategy. Another strategy is withholding care from patients who actually need it. The Journal reported on this, too.